# Johnson & Johnson (JNJ) net assets (shareholders' equity)

URL: https://funkfolio.com/stock/JNJ/net-assets

> Johnson & Johnson (JNJ) net assets (shareholders' equity) were $81.54B at the end of fiscal 2025, up 14.1% from fiscal 2024.

---

## Johnson & Johnson (JNJ) net assets (shareholders' equity)

**Net assets · fiscal 2025:** $81.54B at Dec 31, 2025

Johnson & Johnson (JNJ) had net assets of $81.54B at the end of fiscal 2025 (December 31, 2025). That is 14.1% higher than the $71.49B of fiscal 2024. Figures as of 18 Nov 2026, 21:14 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Net assets, fiscal 2025:** $81.54B
- **Change on fiscal 2024:** +14.1%
- **Highest on record:** $81.54B fiscal 2025
- **Lowest on record:** $42.51B fiscal 2008
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 21:14 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Johnson & Johnson net assets (shareholders' equity), in more detail

Across the 19 fiscal years on record (2007–2025), the highest was $81.54B in fiscal 2025 and the lowest $42.51B in fiscal 2008.

### Net assets by fiscal year

### Johnson & Johnson net assets (shareholders' equity), year by year

Johnson & Johnson (JNJ) net assets (shareholders' equity) by fiscal year

| Fiscal year | Net assets | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $81.54B | 14.1% up | Dec 31, 2025 |
| 2024 | $71.49B | 3.9% up | Dec 31, 2024 |
| 2023 | $68.77B | 10.5% down | Dec 31, 2023 |
| 2022 | $76.80B | — | Dec 31, 2022 |
| 2022 | $74.02B | 17.0% up | Jan 2, 2022 |
| 2021 | $63.28B | — | Jan 3, 2021 |
| 2019 | $59.47B | 0.5% down | Dec 29, 2019 |
| 2018 | $59.75B | 0.7% down | Dec 30, 2018 |
| 2017 | $60.16B | — | Dec 31, 2017 |
| 2017 | $70.42B | 1.0% down | Jan 1, 2017 |
| 2016 | $71.15B | — | Jan 3, 2016 |
| 2014 | $69.75B | 5.8% down | Dec 28, 2014 |
| 2013 | $74.05B | 14.2% up | Dec 29, 2013 |
| 2012 | $64.83B | — | Dec 30, 2012 |
| 2012 | $57.08B | 0.9% up | Jan 1, 2012 |
| 2011 | $56.58B | 11.8% up | Jan 2, 2011 |
| 2010 | $50.59B | — | Jan 3, 2010 |
| 2008 | $42.51B | 1.9% down | Dec 28, 2008 |
| 2007 | $43.32B | — | Dec 30, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

### How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

### Net assets at health care companies of similar size

Net assets of Johnson & Johnson and comparable companies

| Company | Net assets | Fiscal year |
| --- | --- | --- |
| [Eli Lilly LLY](https://funkfolio.com/stock/LLY/net-assets) | $26.54B | 2025 |
| Johnson & Johnson JNJ | $81.54B | 2025 |
| [AbbVie ABBV](https://funkfolio.com/stock/ABBV/net-assets) | -$3.27B | 2025 |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/net-assets) | $52.61B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/net-assets) | $94.11B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/net-assets) | $46.13B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Johnson & Johnson, figure by figure

- [Johnson & Johnson market cap](https://funkfolio.com/stock/JNJ/market-cap)
- [Johnson & Johnson revenue](https://funkfolio.com/stock/JNJ/revenue)
- [Johnson & Johnson earnings](https://funkfolio.com/stock/JNJ/earnings)
- [Johnson & Johnson earnings per share (EPS)](https://funkfolio.com/stock/JNJ/eps)
- [Johnson & Johnson P/E ratio](https://funkfolio.com/stock/JNJ/pe-ratio)
- [Johnson & Johnson P/S ratio](https://funkfolio.com/stock/JNJ/ps-ratio)
- [Johnson & Johnson P/B ratio](https://funkfolio.com/stock/JNJ/pb-ratio)
- [Johnson & Johnson free cash flow](https://funkfolio.com/stock/JNJ/free-cash-flow)
- [Johnson & Johnson operating margin](https://funkfolio.com/stock/JNJ/operating-margin)
- [Johnson & Johnson dividend](https://funkfolio.com/stock/JNJ/dividend)
- [Johnson & Johnson shares outstanding](https://funkfolio.com/stock/JNJ/shares-outstanding)
- [Johnson & Johnson total debt](https://funkfolio.com/stock/JNJ/total-debt)
- [Johnson & Johnson cash on hand](https://funkfolio.com/stock/JNJ/cash)
- [Johnson & Johnson total assets](https://funkfolio.com/stock/JNJ/total-assets)
- [Johnson & Johnson total liabilities](https://funkfolio.com/stock/JNJ/total-liabilities)
- [Johnson & Johnson return on equity (ROE)](https://funkfolio.com/stock/JNJ/roe)
- [Johnson & Johnson return on invested capital (ROIC)](https://funkfolio.com/stock/JNJ/roic)

[Johnson & Johnson (JNJ) overview: price, valuation and scorecard](https://funkfolio.com/stock/JNJ) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Johnson & Johnson net assets (shareholders' equity): questions and answers

**What are Johnson & Johnson's net assets?**

Johnson & Johnson (JNJ) had net assets of $81.54B at the end of fiscal 2025 (December 31, 2025). That is 14.1% higher than the $71.49B of fiscal 2024.

**What are the highest and lowest net assets figures on record for Johnson & Johnson?**

Across the 19 fiscal years on record (2007–2025), the highest was $81.54B in fiscal 2025 and the lowest $42.51B in fiscal 2008.

**How is Johnson & Johnson's net assets calculated?**

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Johnson & Johnson it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: net assets (shareholders' equity)

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Johnson & Johnson (JNJ) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/JNJ/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.
